News about "Wiskott-Aldrich syndrome"

AGC Biologics' Milan Facility Supports Commercial Launch of Waskyra Gene Therapy After US FDA and EU Approval

AGC Biologics' Milan Facility Supports Commercial Launch of Waskyra Gene Therapy After US FDA and EU Approval

AGC Biologics’ Milan Cell and Gene Centre of Excellence will support the commercial rollout of Waskyra following US FDA and EU approvals, strengthening treatment options for patients with Wiskott-Aldrich syndrome.

Wiskott-Aldrich Syndrome | 22/01/2026 | By News Bureau


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members